Diverse health and medical research updates covering pediatric health, cancer treatment, and clinical management.

A study of Irish children born during the initial COVID-19 lockdown found that food allergy rates remained low through age 5, despite normal development of other allergic conditions.

Researchers are evaluating the efficacy of maintenance therapy combining rituximab and lenalidomide versus rituximab alone for older patients with relapsed or refractory follicular lymphoma.

Analysis of hospice care data reveals that while overall disenrollment rates for dementia patients remained stable between 2012 and 2019, the underlying reasons for leaving hospice shifted significantly.

New clinical findings indicate that a higher prepregnancy BMI is linked to a heightened risk of postpartum hypertension, even when adjusted for physical activity levels during pregnancy.

The FDA-approved combination of imlunestrant and abemaciclib offers a new treatment pathway for ESR1-mutated breast cancer, providing a strategic alternative in endocrine therapy timing.

Patients diagnosed with adrenocortical carcinoma and Cushing syndrome face an increased risk of tumor progression if they present with severe cortisol excess at the time of diagnosis.

Clinical evidence suggests that a 7-day course of systemic antibiotics is noninferior to a 4-week course for orthopedic infection patients when combined with intraoperative local antibiotic treatment.

Pediatric patients who experience acute status epilepticus or recurrent seizures following an ischemic stroke are at a higher risk for poor recovery and the development of poststroke epilepsy.